Cited by 173Berberine and alkaloids researchNatural Antidiabetic Agents StudiesMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.

Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials

Derosa, Giuseppe, Maffioli, Pamela, Cicero, Arrigo FG·2012·Expert Opinion on Biological Therapy

DOI 10.1517/14712598.2012.704014

Open this paper in CoChat — free account

Abstract

INTRODUCTION: Type 2 diabetes mellitus and hypercholesterolemia have proven to give an increased incidence of cardiovascular diseases (CVD). Recent studies have suggested that the natural alkaloid berberine could have pharmacological activities potentially useful in diabetes and hypercholesterolemia management. AREAS COVERED: The aim of this review is to evaluate the metabolic properties of the natural alkaloid berberine, and its potential application to the treatment of diabetes and CVD prevention. EXPERT OPINION: Berberine proved to be effective in improving glycemic control and lipid profile. The modern investigation on berberine pharmacological activity is actually developing and numerous scientific evidences are actually in progress and reported in international congresses. The near future perspective is the isolation or neo-synthesis of berberine analogs with a higher bioavailability. The anti-hyperlipidemic and anti-diabetic effects of berberine have to be related to markers of improvement in organ damage in humans; longer trials are needed to better evaluate the safety profile of the molecule, when administered alone or in association with other anti-hyperlipidemic or anti-diabetic drugs, especially in the European population.

Integrity signals

Registry

Crossref · 10.1517/14712598.2012.704014

Cites

92 of 92 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK–S1P signaling pathway
Lan, T., Shen, X., Liu, P., Liu, W., Xu, S., Xie, X. S., Jiang, Q. L., Li, W., & Huang, H. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.07.012 · Cited by 80
Retracted
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
Ogurtsova, K., Fernandes, J. D. D. R., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N. H., Cavan, D. A., Shaw, J. E., & Makaroff, L. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.024 · Cited by 7,121
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67394-1 · Cited by 6,848
IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
Whiting, D. R., Guariguata, L., Weil, C., & Shaw, J. E. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.10.029 · Cited by 4,018
Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes Mellitus<SUBTITLE>Progressive Requirement for Multiple Therapies (UKPDS 49)</SUBTITLE>
Turner, R. C. (1999) · JAMA · doi:10.1001/jama.281.21.2005 · Cited by 2,375
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., Pan, H., et al. (2004) · Nature Medicine · doi:10.1038/nm1135 · Cited by 1,391
Arzneimittelforschung
(2017) · Arzneimittelforschung · doi:10.1055/s-00000175 · Cited by 1,134
Efficacy of berberine in patients with type 2 diabetes mellitus
Yin, J., Xing, H., & Ye, J. (2008) · Metabolism · doi:10.1016/j.metabol.2008.01.013 · Cited by 801
Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine
Imanshahidi, M., & Hosseinzadeh, H. (2008) · Phytotherapy Research · doi:10.1002/ptr.2399 · Cited by 636

Flagged first, then by citations

Show all 91 references

Research works printed but not linked: 12

Birdsall TC, 1997, Altern Med Rev, 2, 94
Lu SS, 2009, J Endocrinol, 200, 159
Leng S, 2004, Acta Pharmacol Sin, 25, 496
Wang SH, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, 24, 926
Han J, 2011, Med Sci Monit, 17, RA164
Peychev L., 2005, Pharmacia, 52, 118
Olmez E, 1992, Arzneimittelforschung, 42, 1095
Ko WH, 2000, Eur J Pharmacol, 399, 187, 10.1016/S0014-2999(00)00339-3 · DOI
Huang WM, 1992, Chin Med J, 105, 1014
Cheng F, 2012, Int J Cardiol
Xu MG, 2008, Cardiology, 112, 279
Huang CG, 1991, Comun Inform Pharm, 9, 10

Sorted by citations

Items 101–173 of 173

Antidiabetic bioactive natural products from medicinal plants
Tresina, P. S., Selvam, M. S., Döss, A., & Mohan, V. R. (2022) · Studies in natural products chemistry · doi:10.1016/b978-0-323-91250-1.00004-5 · Cited by 21
Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism
Liu, Y., Wang, H., Geng, Y.-H., Han, L., Tu, S., & Wang, H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1112088 · Cited by 19
Microbiota transplantation reveals beneficial impact of berberine on hepatotoxicity by improving gut homeostasis
Qin, C., Zhang, H., Zhao, L., Zeng, M., Huang, W., Fu, G., Zhou, W., Wang, H., & Yan, H. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9202-0 · Cited by 19
Thalictrum foliolosum DC: An unexplored medicinal herb from north western Himalayas with potential against fungal pathogens and scavenger of reactive oxygen species
Kumar, R., Sharma, N., Rolta, R., Lal, U. R., Sourirajan, A., Dev, K., & Kumar, V. (2020) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2020.101621 · Cited by 19
Potential of berberine to enhance antimicrobial activity of commonly used antibiotics for dairy cow mastitis caused by multiple drug-resistant Staphylococcus epidermidis infection
Zhou, X., Yang, C., Li, Y., Liu, X., & Wang, Y. (2015) · Genetics and Molecular Research · doi:10.4238/2015.august.19.1 · Cited by 19
Autophagy: A new target for the treatment of atherosclerosis
Sun, Y., & Guan, X. (2018) · Frontiers in Laboratory Medicine · doi:10.1016/j.flm.2018.07.002 · Cited by 17
Effect of a New Formulation of Nutraceuticals as an Add-On to Metformin Monotherapy for Patients with Type 2 Diabetes and Suboptimal Glycemic Control: A Randomized Controlled Trial
Sartore, G., Ragazzi, E., Antonello, G., Cosma, C., & Lapolla, A. (2021) · Nutrients · doi:10.3390/nu13072373 · Cited by 17
The role of autophagy in insulin resistance and glucolipid metabolism and potential use of autophagy modulating natural products in the treatment of type 2 diabetes mellitus
Yang, X., Ding, W., Chen, Z., Lai, K., & Liu, Y. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3762 · Cited by 18
Endothelium-independent vasorelaxant effect of a Berberis orthobotrys root extract via inhibition of phosphodiesterases in the porcine coronary artery
Alamgeer, Chabert, P., Akhtar, M. S., Jabeen, Q., Delecolle, J., Heintz, D., Garo, E., Hamburger, M., Auger, C., Lugnier, C., et al. (2016) · Phytomedicine · doi:10.1016/j.phymed.2016.04.005 · Cited by 17
Retrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in patients with dyslipidemia
Pierro, F. D., Putignano, P., Ferrara, T., Raiola, C., Rapacioli, G., & Villanova, N. (2016) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s120032 · Cited by 16
Emerging roles of circular RNAs in tumorigenesis, progression, and treatment of gastric cancer
Ma, Q., Yang, F., Xiao, B., & Guo, X. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05001-4 · Cited by 17
Overall and Sex-Specific Effect of Berberine on Glycemic and Insulin-Related Traits: a Systematic Review and Meta-Analysis of Randomized Controlled Trials
Zhao, J. V., Huang, X., Zhang, J., Chan, Y., Tse, H., & Blais, J. E. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.08.016 · Cited by 12
Nutraceuticals and Supplements in Management of Prediabetes and Diabetes
Derosa, G., D’Angelo, A., Angelini, F., Belli, L., Cicero, A. F. G., ROS, R. D., Pergola, G. D., Gaudio, G. V., Lupi, A., Sartore, G., et al. (2024) · Nutrients · doi:10.3390/nu17010014 · Cited by 17
Self-citation
Berberine induces pacemaker potential inhibition via cGMP-dependent ATP-sensitive K+ channels by stimulating mu/delta opioid receptors in cultured interstitial cells of Cajal from mouse small intestine
Kim, H. J., Kim, H., Jung, M. H., Kwon, Y. K., & Kim, B. J. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5698 · Cited by 13
The Effects of a New Generation of Nutraceutical Compounds on Lipid Profile and Glycaemia in Subjects with Pre-hypertension
Mazza, A., Schiavon, L., Rigatelli, G., Torin, G., & Lenti, S. (2019) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-019-00332-6 · Cited by 13
Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related Complications
Derosa, G., Maffioli, P., D’Angelo, A., & Pierro, F. D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.582556 · Cited by 14
Self-citation
Berberine: A Rising Star in the Management of Type 2 Diabetes—Novel Insights into Its Anti-Inflammatory, Metabolic, and Epigenetic Mechanisms
Liu, D., Zhao, L., Wang, Y., Wang, L., Wu, D., & Liu, Y. (2025) · Pharmaceuticals · doi:10.3390/ph18121890 · Cited by 12
Topical application of berberine ameliorates imiquimod-induced psoriasis-like dermatitis in BALB/c mice via suppressing JAK1/STAT1 signaling pathway
Chen, Y., Song, S., Wang, Y., Zhang, X., Zhang, J., Wu, L., Wu, J., & Li, X. (2024) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2024.105612 · Cited by 13
Nutraceuticals for the treatment of metabolic diseases: evidence from clinical practice
Derosa, G., & Maffioli, P. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.995630 · Cited by 12
Self-citation
Enhancement of Berberine Hypoglycemic Activity by Oligomeric Proanthocyanidins
Zhang, H., Wang, X., Wang, T., Chen, K., Wang, H., Jia, Q., & Li, Y. (2018) · Molecules · doi:10.3390/molecules23123318 · Cited by 12
Co-encapsulation of berberine and piperine in coaxial electrosprayed chitosan nanoparticles for sustained release and improved berberine bioavailability
Cao‐Luu, N., Luong-Huynh, V.-T., Nguyen‐Thi, B., Nguyen, T.-T., Dang, H.-G., Mac, C.-T., & Ha, H.-T. (2024) · Chemical Papers · doi:10.1007/s11696-024-03381-x · Cited by 11
Applied potential and current applications of alkaloids
Aniszewski, T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-444-59433-4.00006-7 · Cited by 11
Synergy of 2-deoxy-d-glucose combined with berberine in inducing the lysosome/autophagy and transglutaminase activation-facilitated apoptosis
Halicka, H. D., Garcia, J., Li, J., Zhao, H., & Darżynkiewicz, Z. (2016) · APOPTOSIS · doi:10.1007/s10495-016-1315-5 · Cited by 11
Effect of Berberine Plus Bezafibrate Administration on the Lipid Profile of Patients with Mixed Dyslipidemia: A Pilot Clinical Trial
León-Martínez, J. M., Martínez‐Abundis, E., González-Ortı́z, M., & Pérez-Rubio, K. G. (2020) · Journal of Medicinal Food · doi:10.1089/jmf.2020.0029 · Cited by 11
Downregulation of NF-кB signaling is involved in berberine-mediated protection of crucian carp (Carassius auratus gibelio) from cyprinid herpesvirus 2 infection
Su, M., Lu, C., Tang, R., Zhang, X., & Lu, L. (2021) · Aquaculture · doi:10.1016/j.aquaculture.2021.737713 · Cited by 10
Nutraceutical Approaches to Dyslipidaemia: The Main Formulative Issues Preventing Efficacy
Colletti, A., Fratter, A., Pellizzato, M., & Cravotto, G. (2022) · Nutrients · doi:10.3390/nu14224769 · Cited by 10
Berberine prevents the apoptosis of mouse podocytes induced by TRAF5 overexpression by suppressing NF-κB activation
Wu, F. G. H., Yao, D., Lan, T.-Y., Wang, C., Gao, J., Li-qun, H., & Huang, D. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3236 · Cited by 9
Hepatoprotective effects of Berberis vulgaris leaf extract on carbon tetrachloride-induced hepatotoxicity in rats
Omidifar, N., Tahmasebi, M., Sadeghi, H., Nazem, H., & Kokhdan, E. (2018) · Journal of Education and Health Promotion · doi:10.4103/jehp.jehp_48_17 · Cited by 9
Therapeutically relevant natural products as AMPK activators in the treatment of diabetes
Germán-Acacio, J. M., Meza-Sánchez, D. E., & Morales‐Morales, D. (2020) · Studies in natural products chemistry · doi:10.1016/b978-0-12-817907-9.00003-9 · Cited by 10
Prospecting the therapeutic edge of a novel compound (B12) over berberine in the selective targeting of Retinoid X Receptor in colon cancer
Subair, T. I., Soremekun, O. S., Olotu, F. A., & Soliman, M. E. S. (2021) · Journal of Molecular Modeling · doi:10.1007/s00894-021-04848-4 · Cited by 9
The association between circulatory, local pancreatic PCSK9 and type 2 diabetes mellitus: The effects of antidiabetic drugs on PCSK9
Lu, F., Li, E., & Yang, X. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19371 · Cited by 8
Clinical Efficacy of Curcumin, Resveratrol, Silymarin, and Berberine on Cardio‐Metabolic Risk Factors Among Patients With Type 2 Diabetes Mellitus: A Systemic Review and Bayesian Network Meta‐Analysis
Miao, R., Zhang, B., Zhou, D., Kang, M., Tian, J., Zhao, L., & Tong, X. (2025) · Phytotherapy Research · doi:10.1002/ptr.8431 · Cited by 12
Three arms, double-blind, non-inferiority, randomized clinical study testing the lipid-lowering effect of a novel dietary supplement containing red yeast rice and artichoke extracts compared to Armolipid Plus® and placebo
Cicero, A. F. G., Fogacci, F., Tocci, G., D’Addato, S., Grandi, E., Banach, M., & Borghi, C. (2023) · Archives of Medical Science · doi:10.5114/aoms/167969 · Cited by 9
Self-citation
Statins and Nutraceuticals/Functional Food: Could They Be Combined?
Cicero, A. F. G., & Colletti, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-20433-8_11 · Cited by 8
Self-citation
Metabolic effects of the association Berberis aristata/Silybum marianum: a preliminary double-blind, placebo-controlled study in obese patients with type 2 diabetes
Guarino, G., Corte, T. D., Sofia, M., Carbone, L., Marino, G., Martedì, E., & Gentile, S. (2015) · Nutrafoods · doi:10.1007/s13749-015-0052-7 · Cited by 9
LianXia Formula Granule Attenuates Cardiac Sympathetic Remodeling in Rats with Myocardial Infarction via the NGF/TrKA/PI3K/AKT Signaling Pathway
Li, S.-S., Kang, N., Li, X., Yuan, J., Ling, R., Li, P., & Li, J.-L. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5536406 · Cited by 7
Reduction of cholesterol and other cardiovascular disease risk factors by alternative therapies
Tappia, P. S., Xu, Y., & Dhalla, N. S. (2013) · Clinical Lipidology · doi:10.2217/clp.13.24 · Cited by 7
Phenanthroline-linked berberine dimer and fluorophore-tagged DNA conjugate for the selective detection of microRNA-185: Experimental and molecular docking studies
Hu, X., Li, R.-T., Zhang, M., Wu, K.-Y., Li, H., Huang, N.-H., Sun, B., & Chen, J.-X. (2018) · Analytica Chimica Acta · doi:10.1016/j.aca.2018.11.022 · Cited by 7
Plausible Links Between Metabolic Networks, Stem Cells, and Longevity
Kucia, M., & Ratajczak, M. Z. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-31206-0_15 · Cited by 6
Potential antihypertensive activity of novel peptides from green basil leaves
Prangthip, P., Panbangred, W., & Reamtong, O. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04098-2 · Cited by 4
Mitochondria as a Target for Safety and Toxicity Evaluation of Nutraceuticals
Teodoro, J. S., Duarte, F. V., Rolo, A. P., & Palmeira, C. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802147-7.00028-0 · Cited by 4
Berberine for Adjunct/Alternative Treatment of Dyslipidemia: A Literature Review
Evbayekha, E. O., Nwachukwu, E. U., Nikravesh, E., Rosas, V., Onuegbu, C. A., Egwuonwu, O. F., Eguagie, O., Chioma, O. E., Agho, A. V., Samuels, K. A., et al. (2023) · Cureus · doi:10.7759/cureus.39261 · Cited by 3
Berberine-Promoted CXCR4 Expression Accelerates Endothelial Repair Capacity of Early Endothelial Progenitor Cells in Persons with Prehypertension
Shao, Y., Tao, J., Yu, B., Meng, D., Yang, X., Sun, J., Qiu, Y., & Zhang, X. (2018) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-018-2568-3 · Cited by 3
Berberine–cinnamic acid co‐crystal effect in ameliorating hyperlipidemia might be regulated through the PI3K / AKT / mTOR / SREBP ‐1 signaling pathway
Gao, W., Li, Y., Chen, L., Yang, W., He, Y., Yang, Y., Yin, D., & Tan, S. (2025) · FEBS Open Bio · doi:10.1002/2211-5463.70115 · Cited by 2
Enantioselective Complexation of Xylopinine: A Cyclodextrin-Assisted CE and NMR Study
Várnagy, E., Tóth, G., Hosztafi, S., Malanga, M., Fejős, I., & Béni, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199405 · Cited by 2
Berberine-gut microbiota interactions based on CiteSpace: current research status and hotspots
Chen, Y., Chen, T., Tian, S. J., Tao, L., Fan, F., Yang, Y., & Shen, X. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1751887 · Cited by 2
Exploring the use of saponin as a biosurfactant for formulating niosomal carriers to regulate the release of berberine
Shiri, S., Gharanjig, K., Hosseinnezhad, M., Tahghighi, A., & Etezad, M. (2025) · Journal of Dispersion Science and Technology · doi:10.1080/01932691.2025.2462691 · Cited by 2
Mitochondria as a target for safety and toxicity evaluation of nutraceuticals
Teodoro, J. S., Machado, I. F., Castela, A. C., Rolo, A. P., & Palmeira, C. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821038-3.00030-6 · Cited by 3
Application of Berberine on Skin Diseases: A Review
Dhiman, K., Sharma, A., Sharma, A., Goyal, K., Pandit, V. R., Ashawat, M. S., & Jindal, S. (2022) · Research Journal of Pharmaceutical Dosage Forms and Technology · doi:10.52711/0975-4377.2022.00050 · Cited by 2
Antidiabetic activity of Akar Kuning (Fibraurea tinctoria Lour) Extract in Alloxan-Induced Diabetic White Male Rats
Supomo, S., Syamsul, E. S., Sa’adah, H., Kintoko, K., & Witasari, H. A. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00059 · Cited by 2
Berberine-Drug Interactions: Mechanisms, Clinical Relevance and Risk Stratification-A Narrative Review
Dumitru, C. N., Marcu, T., Dumitru, A. O., Tudor, S. S., Ferțu, I. D., Elisei, A.-M., & Goroftei, L. (2026) · Pharmaceuticals · doi:10.3390/ph19081313 · Cited by 2
“Meta-analyses of randomized trials confirm significant reductions in glycated hemoglobin, fasting glucose and lipid profile with berberine [25–28], and its metabolic efficacy has been compared, in some syntheses and combination clinical studies, with that of common oral hypoglycemic agents [29–31].”
Biological targets of berberine hydrochloride and the mechanisms by which it alleviates metabolic-associated fatty liver disease
Liang, J., & Gu, A. (2022) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2022-0696 · Cited by 1
NUTRACEUTICALS IN DYSLIPIDEMIA: AN ALTERNATIVE APPROACH
Agarwal, S., Thomson, S. R., & Gangachannaiah, S. (2016) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2017.v10i1.15360 · Cited by 1
Phytonanoparticles toward the treatment of diabetes
Shelke, T., Talegaonkar, S., & Mishra, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99616-7.00027-x · Cited by 1
Non-pharmaceutical treatment of dyslipidemia: review of current methods of diet and nutraceuticals
Polenova, N., Kosura, S. D., Varaeva, Y. R., Николаевна, Л. Е., & Starodubova, A. V. (2019) · Kardiologiia · doi:10.18087/cardio.2549 · Cited by 1
Combination of metformin and berberine represses the apoptosis of sebocytes in high‐fat diet‐induced diabetic hamsters and an insulin‐treated human cell line
Yao, Y., Zuo, J. L., Chen, L., & Wei, Y. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3504 · Cited by 1
Possible therapies for obesity: Focus on the available options for its treatment
Derosa, G., & Maffioli, P. (2014) · Nutrition · doi:10.1016/j.nut.2014.09.005
Self-citation
Addressing Obesity in Orthopedics
Aston, B. C. (2019) · JBJS Journal of Orthopaedics for Physician Assistants · doi:10.2106/jbjs.jopa.19.00004
The Surgical Rehabilitation of the Amputee.
Basmajian, J. V. (1980) · Europe PMC (PubMed Central)
Goldenseal
Edwards, S. E., Rocha, I. D. C., Williamson, E. M., & Heinrich, M. (2015) · doi:10.1002/9781118543436.ch50
Nutraceutical alternatives to red yeast rice extract/monacolin K for moderate hypercholesterolaemia: Current evidence and knowledge gaps: Nutraceuticals and hypercholesterolaemia
Comi, L., Giglione, C., Klinaku, F. T., Parolini, C., Olivieri, C., Ruzza, M., Tollemeto, V., Zurlo, M., Pialorsi, F., Seneci, A., et al. (2023) · European Atherosclerosis Journal · doi:10.56095/eaj.v1i3.20
Functional Foods: Potential Activity For Controlling Heart Disease
Biswas, K., Karmakar, I., Mandal, S., Das, S., Sahoo, S., & Tewari, S. (2023) · Journal Of Advanced Zoology · doi:10.53555/jaz.v44is5.3223
Effect of Four Weeks of Aerobic Exercise and Berberine Supplementation on the Expression of Dopamine 5 Receptor and Poly (Adenosin Diphosphat [ADP]-Ribose) Polymerase Genes in the Heart Tissue of Methamphetamine-Exposed Rats
Aghajani, Z. S., Rajabi, S., & Ziaolhagh, S. J. (2024) · مجله علمی دانشگاه علوم پزشکی گرگان · doi:10.61186/goums.26.3.28
Bioprospecting ethnopharmacological plants for endophytic fungal drug discovery
Buddha, S., Gambhir, L., Kumar, Y., Sharma, G., Sharma, A., & Kapoor, N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-31484-1.00001-3
Antidiabetic drugs: patent case studies
Telange, D. R., Telrandhe, U. B., Shete, V. S., & Pethe, A. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30086-8.00013-9
Additional file 1 of Potential antihypertensive activity of novel peptides from green basil leaves
Prangthip, P., Panbangred, W., & Reamtong, O. (2023) · Figshare · doi:10.6084/m9.figshare.23908849
Harnessing the power of phytochemicals: Natural strategies for the prevention of heart disease
Upadhyay, S., Chauhan, M., Ghosh, S., & Kanabar, V. (2026) · EPJ Web of Conferences · doi:10.1051/epjconf/202634801007
Berberine: A Natural Compound with Broad-Spectrum Pharmacological Effects and Translational Potential
Tanwar, S. S., Sharma, S., & Gupta, A. (2025) · International Journal of Newgen Research in Pharmacy & Healthcare · doi:10.61554/ijnrph.v3i2.2025.187
Effets des enképhalines sur la contractilité intestinale : conséquences sur l'axe intestin-cerveau-périphérie dans le contrôle du métabolisme glucidique
Bessac, A. (2020) · theses.fr (ABES) · doi:10.70675/f11cd9b9zb198z454az9c2fz08ca0bfdd5d9
Berberine as a Phytochemical in Metabolic Syndrome Management: Mechanistic Insights and Clinical Evidence
Muneer, A., Noor, M., Jamshed, S., Shahid, A., Anjum, A., Parveen, F., Rahman, A., & Ali, P. A. (2026) · medtigo Journal of Pharmacology · doi:10.63096/medtigo3061322
Berberine as a nutritional pharmacotherapeutic agent: Unraveling Its mechanisms and clinical potential
Kumar, A., Thakur, R., Aggarwal, K., Sood, N., Patel, P., Patel, M. K., Patel, G., & Kurmi, B. D. (2026) · PharmaNutrition · doi:10.1016/j.phanu.2026.100533
BindingDB Entry 50007333: Isoquinoline Alkaloids from Berberis vulgaris as Potential Lead Compounds for the Treatment of Alzheimer's Disease.
BindingDB (2021) · UC San Diego · doi:10.7270/q2nz8bxf
BindingDB Entry 50010596: Structure-Activity Relationship Study Enables the Discovery of a Novel
BindingDB (2021) · UC San Diego · doi:10.7270/q2r78jrc

Authors: Derosa, G., Maffioli, P., & Cicero, A. F.
Affiliations: University of Pavia (IT)
University of Bologna (IT)
ORCID: Derosa, Giuseppe
Maffioli, Pamela
Cicero, Arrigo FG
Venue: Expert Opinion on Biological Therapy
Publisher: Informa UK Limited
Published: 2012-07-11
Volume: 12
Issue: 8
Pages: 1113-1124
ISSN: 1471-2598 (ISSN-L)
1744-7682
DOI: 10.1517/14712598.2012.704014
OpenAlex: W2008978505
Cited by: 171
References: 91
Citations by year: 2026: 5 · 2025: 8 · 2024: 10 · 2023: 12 · 2022: 10 · 2021: 9 · 2020: 17 · 2019: 8 · 2018: 16 · 2017: 10 · 2016: 21 · 2015: 19 · 2014: 16 · 2013: 8 · 2012: 1
FWCI: 1.63
Type: journal article
Language: en
Update notices: expression_of_concern (2018-05-16)
addendum (2018-05-11)
Open access: closed
Locations: Expert Opinion on Biological Therapy (publishedVersion)
PubMed (publishedVersion)
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Berberine and alkaloids research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: berberine, type 2 diabetes, hypercholesterolemia, cardiovascular disease prevention, glycemic control, lipid profile, hypolipidemic effect, anti-diabetic effects, bioavailability, drug safety, natural alkaloids
MeSH terms: Animals, Anticholesteremic Agents, Berberine Alkaloids, Blood Glucose, Cardiovascular Diseases, Cholesterol, Diabetes Mellitus, Type 2, Humans, Hypercholesterolemia, Hypoglycemic Agents, Risk Factors, Biomarkers, Treatment Outcome, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks